Impact of Vitamin D Repletion in Hemodialysis Patients

Completed · Not applicable

Conditions studied: Vitamin D Deficiency, End-stage Renal Disease

In brief

Dialysis patients often suffer from defects in their immune system (that part of the body which fights infection). Evidence suggests that Vitamin D deficiency may have a negative effect on immunity, and many dialysis patients are deficient in Vitamin D. We believe that by giving Vitamin D to dialysis patients who are deficient, we may help improve their immune system. This study will test that idea.

Key facts

Study ID

NCT01175798

Run by

Mehrotra, Anita, M.D.

People needed

116

Starts

2010-08-01

Expected to finish

2013-08-01

Last updated by the study team

2014-09-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Chronic hemodialysis treatments for at least 2 consecutive months
• 25OH-Vitamin D level < 25 ng/mL (inclusion criteria for randomization)

You may not qualify if…

• History of acute renal failure requiring dialysis with potential for renal recovery
• History of HIV/AIDS
• Inability to provide informed consent

Where it is running

• Mount Sinai School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.